| 000 | 01505 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515113652.0 | ||
| 264 | 0 | _c20090701 | |
| 008 | 200907s 0 0 eng d | ||
| 022 | _a1078-1439 | ||
| 024 | 7 |
_a10.1016/j.urolonc.2007.11.033 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLerner, Seth P | |
| 245 | 0 | 0 |
_aFailure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer. _h[electronic resource] |
| 260 |
_bUrologic oncology _c |
||
| 300 |
_a155-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBCG Vaccine _xtherapeutic use |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Invasiveness |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aRegression Analysis |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xdrug therapy |
| 700 | 1 | _aTangen, Catherine M | |
| 700 | 1 | _aSucharew, Heidi | |
| 700 | 1 | _aWood, David | |
| 700 | 1 | _aCrawford, E David | |
| 773 | 0 |
_tUrologic oncology _gvol. 27 _gno. 2 _gp. 155-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.urolonc.2007.11.033 _zAvailable from publisher's website |
| 999 |
_c17867413 _d17867413 |
||